A detailed history of North Rock Partners, LLC transactions in Mckesson Corp stock. As of the latest transaction made, North Rock Partners, LLC holds 936 shares of MCK stock, worth $462,580. This represents 0.05% of its overall portfolio holdings.

Number of Shares
936
Previous 1,069 12.44%
Holding current value
$462,580
Previous $573,000 4.71%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$518.81 - $607.81 $69,001 - $80,838
-133 Reduced 12.44%
936 $546,000
Q1 2024

May 07, 2024

BUY
$473.42 - $539.26 $121,195 - $138,050
256 Added 31.49%
1,069 $573,000
Q4 2023

Feb 08, 2024

BUY
$437.42 - $470.64 $97,107 - $104,482
222 Added 37.56%
813 $376,000
Q3 2023

Oct 24, 2023

BUY
$402.4 - $446.42 $237,818 - $263,834
591 New
591 $256,000
Q1 2023

May 03, 2023

BUY
$335.35 - $386.06 $189,472 - $218,123
565 New
565 $201,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $71B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.